SmallCap
CompaniesStatistics

(주)서지넥스

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)서지넥스
Business Reg. No.4608602000
CEO김세준
Address서울특별시 서초구
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products신약개발
EstablishedContact
Phone02-592-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.110111-*******

Investment Metrics


Market Cap
-
Op. Margin
-22,900.5%
ROE
-32.13%
Debt Ratio
26.66%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2021-03-22 ~ 2023-03-21202101023102021-03-22
벤처투자유형2023-05-31 ~ 2026-05-30202305310100142021-03-22

Financial Statements


3-Year Financial Data

Revenue CAGR -83.3%

Item202420232022
Revenue

0.1B

0.7B

0.0B

Operating Profit

-27.9B

-16.6B

-7.3B

Net Profit

-18.0B

-40.7B

-7.6B

Total Assets

71.0B

7.0B

42.2B

Total Liabilities

14.9B

17.9B

12.4B

Total Equity

56.0B

-10.9B

29.8B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
121810K

66.6%

vs. 3-Year Avg.: 364910K
Operating Profit
-28B

133.9%

vs. 3-Year Avg.: -12B
Op. Margin
-22900.5%

908.7%

vs. 3-Year Avg.: -2270.2%
Debt Ratio
26.7%

143.6%

vs. 3-Year Avg.: -61.2%
ROE
-32.1%

118.5%

vs. 3-Year Avg.: 173.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김세준대표이사대표

Employment Status


Regular EmployeesContact
CEO김세준

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울특별시 서초구",
  "ceo_name": "김세준",
  "certificate": [
    {
      "cert_number": "20210102310",
      "changes": "",
      "disclosure_date": "2021-03-22",
      "first_cert_date": "2021-03-22",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2021-03-22 ~ 2023-03-21"
    },
    {
      "cert_number": "20230531010014",
      "changes": "",
      "disclosure_date": "2023-05-31",
      "first_cert_date": "2021-03-22",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2023-05-31 ~ 2026-05-30"
    }
  ],
  "company_name": "(주)서지넥스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 120640000,
      "cost_of_sales": 0,
      "current_assets": 750036000,
      "current_liabilities": 342591000,
      "gross_profit": 0,
      "net_income": -760745000,
      "net_income_bs": -760745000,
      "non_current_assets": 3474097000,
      "non_current_liabilities": 900000000,
      "non_operating_expenses": 48806000,
      "non_operating_income": 15316000,
      "operating_profit": -727255000,
      "revenue": 0,
      "sga_expenses": 727255000,
      "total_assets": 4224133000,
      "total_equity": 2981542000,
      "total_liabilities": 1242591000
    },
    "2023": {
      "capital_stock": 120640000,
      "cost_of_sales": 0,
      "current_assets": 82742000,
      "current_liabilities": 306965000,
      "gross_profit": 72970000,
      "net_income": -4072799000,
      "net_income_bs": -4072799000,
      "non_current_assets": 615966000,
      "non_current_liabilities": 1483000000,
      "non_operating_expenses": 3038382000,
      "non_operating_income": 622144000,
      "operating_profit": -1656561000,
      "revenue": 72970000,
      "sga_expenses": 1729531000,
      "total_assets": 698708000,
      "total_equity": -1091257000,
      "total_liabilities": 1789965000
    },
    "2024": {
      "capital_stock": 180966000,
      "cost_of_sales": 0,
      "current_assets": 5914395000,
      "current_liabilities": 1488959000,
      "gross_profit": 12175000,
      "net_income": -1800463000,
      "net_income_bs": -1800463000,
      "non_current_assets": 1184410000,
      "non_current_liabilities": 5347000,
      "non_operating_expenses": 101329000,
      "non_operating_income": 1088997000,
      "operating_profit": -2788131000,
      "revenue": 12175000,
      "sga_expenses": 2800306000,
      "total_assets": 7098805000,
      "total_equity": 5604499000,
      "total_liabilities": 1494306000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,000,016,000",
      "changes": "2,000,016,000",
      "date": "2021-10-15"
    },
    {
      "amount": "2,000,016,000",
      "changes": "2,000,016,000",
      "date": "2021-10-15"
    }
  ],
  "main_products": "신약개발",
  "phone": "02-592-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected